Biorce
What They Do
AI-driven clinical trials platform accelerating drug development. Uses machine learning to optimize trial design, patient recruitment, and protocol optimization.
Funding
Valuation: ~€200M implied ($52.5M Series A, 2025) €43.8M Series A (2025)